Integrin activation is required for VEGF and FGF receptor protein presence on human microvascular endothelial cells

被引:0
作者
Raymond Tsou
F. Frank Isik
机构
[1] University of Washington Medical Center,Department of Surgery, VA Puget Sound Health Care System and
来源
Molecular and Cellular Biochemistry | 2001年 / 224卷
关键词
integrins; extracellular matrix; growth factor receptors; microvascular; endothelial cell; angiogenesis;
D O I
暂无
中图分类号
学科分类号
摘要
Endothelial cell proliferation and migration is initiated by growth factors including FGF and VEGF that bind to specific transmembrane receptor tyrosine kinases. Mechanisms that regulate in vivo expression of fibroblast growth factor receptors (FGFR) and vascular endothelial growth factor receptors (VEGFR) are not well understood. Since it is well known that different matrices influence the proliferation and migration of endothelial cells in culture, we hypothesized that changes in the extracellular matrix environment can regulate growth factor receptors on endothelial cells. We cultured human microvascular endothelial cells on different matrices (vitronectin, laminin, fibronectin, fibrin, and collagen IV) and examined for the presence of growth factor receptors (FGFR-1, FGFR-2, VEGFR-1, and VEGFR-2). We show that vitronectin increased the presence of all four growth factor receptors and most notably, VEGFR-1. In contrast, fibrin decreased all four receptors, especially FGFR-1 and FGFR-2. Inhibiting phosphotyrosine signaling abolished immunostaining for all four receptors, regardless of the matrix, but was not dependent on activating the Fyn-Shc pathway. Cells plated on vitronectin in the presence of blocking antibodies to integrins αvβ3 and αvβ5 similarly decreased presence of these growth factor receptors. Our data suggests a possible mechanism of how matrix-integrin interactions regulate endothelial cell responsiveness to growth factors and anchorage-dependent cell growth.
引用
收藏
页码:81 / 89
页数:8
相关论文
共 150 条
  • [31] Yasuno H(1970)Extracellular matrix of newly forming vessels - an immunohistochemical study Nature 227 680-685
  • [32] Werner S(1997)The microvascular extracellular matrix. Developmental changes during angiogenesis in the aortic ring-plasma clot model J Gastroenterol 32 119-121
  • [33] Peters KG(1995)Transient functional expression of alphaVbeta 3 on vascular cells during wound repair J Mol Med 73 333-346
  • [34] Longaker MT(1992)Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 359 845-848
  • [35] Fuller-Pace F(1991)Plasma level of basic fibroblast growth factor increases with progression of chronic liver disease Proc Natl Acad Sci USA 88 565-569
  • [36] Banda MJ(1990)Angiogenesis: Mechanistic insights, neovascular diseases, and therapeutic prospects Cancer Metastasis Rev 9 227-238
  • [37] Williams LT(1999)Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas Cell 97 727-741
  • [38] Underwood PA(1998)Injury induces Biol Cell 90 381-390
  • [39] Bennett FA(1994) expression of platelet-derived growth factor (PDGF) and PDGF receptor mRNAs in skin epithelial cells and PDGF mRNA in connective tissue fibroblasts Cell 79 1157-1164
  • [40] Madri JA(1994)Modes of FGF release Science 264 569-571